aluates Reports

$ 0.0

Automative

Global CRISPR and CRISPR-Associated (Cas) Genes Market Research Report 2026

Published Date: 2026-02-06

Report Code: QYRE-Auto-39I6706

China CRISPR and CRISPR Associated Cas Genes Market Report Forecast 2021 2027

BUY CHAPTERS

Global CRISPR and CRISPR-Associated (Cas) Genes Market Research Report 2026

Code: QYRE-Auto-39I6706

Report

2026-02-06

Pages:118

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Thermo Fisher Scientific

Editas Medicine

Caribou Biosciences

CRISPR Therapeutics

Intellia Therapeutics Inc

CELLECTIS

Horizon Discovery Plc

Sigma-aldrich

Precision Biosciences

GenScript

Sangamo BioSciences, Inc.

Lonza Group Limited

Integrated DNA Technologies

New England Biolabs

Origene Technologies

CRISPR and CRISPR-Associated (Cas) Genes Market Size

The global CRISPR and CRISPR-Associated (Cas) Genes market was valued at US$ 3087 million in 2025 and is anticipated to reach US$ 20920 million by 2032, at a CAGR of 31.9% from 2026 to 2032.

CRISPR and CRISPR-Associated (Cas) Genes Market

This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.

Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.

The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.

Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.

By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell"s genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS"s choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.

Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.

CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.

This report delivers a comprehensive overview of the global CRISPR and CRISPR-Associated (Cas) Genes market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding CRISPR and CRISPR-Associated (Cas) Genes. The CRISPR and CRISPR-Associated (Cas) Genes market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global CRISPR and CRISPR-Associated (Cas) Genes market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist CRISPR and CRISPR-Associated (Cas) Genes manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of CRISPR and CRISPR-Associated (Cas) Genes Market Report

Report Metric	Details
Report Name	CRISPR and CRISPR-Associated (Cas) Genes Market
Accounted market size in 2025	US$ 3087 million
Forecasted market size in 2032	US$ 20920 million
CAGR	31.9%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Genome Editing Genetic engineering gRNA Database/Gene Librar CRISPR Plasmid Human Stem Cells Genetically Modified Organisms/Crops Cell Line Engineering
Segment by Application	Biotechnology Companies Pharmaceutical Companies Academic Institutes Research and Development Institutes
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Cellectis, Horizon Discovery Plc, Sigma Aldrich, Precision Biosciences, Genscript, Sangamo Biosciences Inc., Lonza Group Limited, Integrated DNA Technologies, New England Biolabs, Origene Technologies
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for CRISPR and CRISPR-Associated (Cas) Genes companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is CRISPR and CRISPR-Associated (Cas) Genes Market growing?

Ans: The CRISPR and CRISPR-Associated (Cas) Genes Market witnessing a CAGR of 31.9% during the forecast period 2026-2032.

What is the CRISPR and CRISPR-Associated (Cas) Genes Market size in 2032?

Ans: The CRISPR and CRISPR-Associated (Cas) Genes Market size in 2032 will be US$ 20920 million.

What is the market share of major companies in CRISPR and CRISPR-Associated (Cas) Genes Market?

Ans: Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.

What is the CRISPR and CRISPR-Associated (Cas) Genes Market share by region?

Ans: Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.

Who are the main players in the CRISPR and CRISPR-Associated (Cas) Genes Market report?

Ans: The main players in the CRISPR and CRISPR-Associated (Cas) Genes Market are Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Cellectis, Horizon Discovery Plc, Sigma Aldrich, Precision Biosciences, Genscript, Sangamo Biosciences Inc., Lonza Group Limited, Integrated DNA Technologies, New England Biolabs, Origene Technologies

What are the Application segmentation covered in the CRISPR and CRISPR-Associated (Cas) Genes Market report?

Ans: The Applications covered in the CRISPR and CRISPR-Associated (Cas) Genes Market report are Biotechnology Companies, Pharmaceutical Companies, Academic Institutes, Research and Development Institutes

What are the Type segmentation covered in the CRISPR and CRISPR-Associated (Cas) Genes Market report?

Ans: The Types covered in the CRISPR and CRISPR-Associated (Cas) Genes Market report are Genome Editing, Genetic engineering, gRNA Database/Gene Librar, CRISPR Plasmid, Human Stem Cells, Genetically Modified Organisms/Crops, Cell Line Engineering

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Genome Editing

1.2.3 Genetic engineering

1.2.4 gRNA Database/Gene Librar

1.2.5 CRISPR Plasmid

1.2.6 Human Stem Cells

1.2.7 Genetically Modified Organisms/Crops

1.2.8 Cell Line Engineering

1.3 Market by Application

1.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Biotechnology Companies

1.3.3 Pharmaceutical Companies

1.3.4 Academic Institutes

1.3.5 Research and Development Institutes

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Perspective (2021–2032)

2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Growth Trends by Region

2.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Region (2021–2026)

2.2.3 CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Region (2027–2032)

2.3 CRISPR and CRISPR-Associated (Cas) Genes Market Dynamics

2.3.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Trends

2.3.2 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers

2.3.3 CRISPR and CRISPR-Associated (Cas) Genes Market Challenges

2.3.4 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue

3.1.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue (2021–2026)

3.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Players (2021–2026)

3.2 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by CRISPR and CRISPR-Associated (Cas) Genes Revenue

3.4 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio

3.4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2025

3.5 Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes Head Offices and Areas Served

3.6 Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Products and Applications

3.7 Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Type

4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Type (2021–2026)

4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2027–2032)

5 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Application

5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Application (2021–2026)

5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size (2021–2032)

6.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2021–2026)

6.4 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size (2021–2032)

7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2021–2026)

7.4 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size (2021–2032)

8.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2021–2026)

8.4 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size (2021–2032)

9.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2021–2026)

9.4 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size (2021–2032)

10.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2021–2026)

10.4 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Details

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Introduction

11.1.4 Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Editas Medicine

11.2.1 Editas Medicine Company Details

11.2.2 Editas Medicine Business Overview

11.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Introduction

11.2.4 Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

11.2.5 Editas Medicine Recent Development

11.3 Caribou Biosciences

11.3.1 Caribou Biosciences Company Details

11.3.2 Caribou Biosciences Business Overview

11.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction

11.3.4 Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

11.3.5 Caribou Biosciences Recent Development

11.4 CRISPR therapeutics

11.4.1 CRISPR therapeutics Company Details

11.4.2 CRISPR therapeutics Business Overview

11.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Introduction

11.4.4 CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

11.4.5 CRISPR therapeutics Recent Development

11.5 Intellia therapeutics, Inc.

11.5.1 Intellia therapeutics, Inc. Company Details

11.5.2 Intellia therapeutics, Inc. Business Overview

11.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction

11.5.4 Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

11.5.5 Intellia therapeutics, Inc. Recent Development

11.6 Cellectis

11.6.1 Cellectis Company Details

11.6.2 Cellectis Business Overview

11.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Introduction

11.6.4 Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

11.6.5 Cellectis Recent Development

11.7 Horizon Discovery Plc

11.7.1 Horizon Discovery Plc Company Details

11.7.2 Horizon Discovery Plc Business Overview

11.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Introduction

11.7.4 Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

11.7.5 Horizon Discovery Plc Recent Development

11.8 Sigma Aldrich

11.8.1 Sigma Aldrich Company Details

11.8.2 Sigma Aldrich Business Overview

11.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Introduction

11.8.4 Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

11.8.5 Sigma Aldrich Recent Development

11.9 Precision Biosciences

11.9.1 Precision Biosciences Company Details

11.9.2 Precision Biosciences Business Overview

11.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction

11.9.4 Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

11.9.5 Precision Biosciences Recent Development

11.10 Genscript

11.10.1 Genscript Company Details

11.10.2 Genscript Business Overview

11.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Introduction

11.10.4 Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

11.10.5 Genscript Recent Development

11.11 Sangamo Biosciences Inc.

11.11.1 Sangamo Biosciences Inc. Company Details

11.11.2 Sangamo Biosciences Inc. Business Overview

11.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction

11.11.4 Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

11.11.5 Sangamo Biosciences Inc. Recent Development

11.12 Lonza Group Limited

11.12.1 Lonza Group Limited Company Details

11.12.2 Lonza Group Limited Business Overview

11.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Introduction

11.12.4 Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

11.12.5 Lonza Group Limited Recent Development

11.13 Integrated DNA Technologies

11.13.1 Integrated DNA Technologies Company Details

11.13.2 Integrated DNA Technologies Business Overview

11.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction

11.13.4 Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

11.13.5 Integrated DNA Technologies Recent Development

11.14 New England Biolabs

11.14.1 New England Biolabs Company Details

11.14.2 New England Biolabs Business Overview

11.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Introduction

11.14.4 New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

11.14.5 New England Biolabs Recent Development

11.15 Origene Technologies

11.15.1 Origene Technologies Company Details

11.15.2 Origene Technologies Business Overview

11.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction

11.15.4 Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

11.15.5 Origene Technologies Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

Editas Medicine

Caribou Biosciences

CRISPR Therapeutics

Intellia Therapeutics Inc

CELLECTIS

Horizon Discovery Plc

Sigma-aldrich

Precision Biosciences

GenScript

Sangamo BioSciences, Inc.

Lonza Group Limited

Integrated DNA Technologies

New England Biolabs

Origene Technologies

List of Tables

Table 1. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Genome Editing

Table 3. Key Players of Genetic engineering

Table 4. Key Players of gRNA Database/Gene Librar

Table 5. Key Players of CRISPR Plasmid

Table 6. Key Players of Human Stem Cells

Table 7. Key Players of Genetically Modified Organisms/Crops

Table 8. Key Players of Cell Line Engineering

Table 9. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 10. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 11. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (US$ Million), 2021–2026

Table 12. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2021–2026)

Table 13. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Region (US$ Million), 2027–2032

Table 14. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2027–2032)

Table 15. CRISPR and CRISPR-Associated (Cas) Genes Market Trends

Table 16. CRISPR and CRISPR-Associated (Cas) Genes Market Drivers

Table 17. CRISPR and CRISPR-Associated (Cas) Genes Market Challenges

Table 18. CRISPR and CRISPR-Associated (Cas) Genes Market Restraints

Table 19. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Players (US$ Million), 2021–2026

Table 20. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Players (2021–2026)

Table 21. Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Tier (Tier 1, Tier 2, and Tier 3), based on CRISPR and CRISPR-Associated (Cas) Genes Revenue, 2025

Table 22. Ranking of Global Top CRISPR and CRISPR-Associated (Cas) Genes Companies by Revenue (US$ Million) in 2025

Table 23. Global 5 Largest Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue (CR5 and HHI), 2021–2026

Table 24. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Headquarters and Area Served

Table 25. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Products and Applications

Table 26. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Date of General Availability (GA)

Table 27. Mergers and Acquisitions, Expansion Plans

Table 28. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (US$ Million), 2021–2026

Table 29. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2021–2026)

Table 30. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (US$ Million), 2027–2032

Table 31. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2027–2032)

Table 32. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (US$ Million), 2021–2026

Table 33. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2021–2026)

Table 34. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (US$ Million), 2027–2032

Table 35. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2027–2032)

Table 36. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (US$ Million), 2021–2026

Table 38. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (US$ Million), 2027–2032

Table 39. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 40. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (US$ Million), 2021–2026

Table 41. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (US$ Million), 2027–2032

Table 42. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 43. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (US$ Million), 2021–2026

Table 44. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (US$ Million), 2027–2032

Table 45. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (US$ Million), 2021–2026

Table 47. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (US$ Million), 2027–2032

Table 48. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 49. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (US$ Million), 2021–2026

Table 50. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (US$ Million), 2027–2032

Table 51. Thermo Fisher Scientific Company Details

Table 52. Thermo Fisher Scientific Business Overview

Table 53. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product

Table 54. Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026

Table 55. Thermo Fisher Scientific Recent Development

Table 56. Editas Medicine Company Details

Table 57. Editas Medicine Business Overview

Table 58. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product

Table 59. Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026

Table 60. Editas Medicine Recent Development

Table 61. Caribou Biosciences Company Details

Table 62. Caribou Biosciences Business Overview

Table 63. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product

Table 64. Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026

Table 65. Caribou Biosciences Recent Development

Table 66. CRISPR therapeutics Company Details

Table 67. CRISPR therapeutics Business Overview

Table 68. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product

Table 69. CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026

Table 70. CRISPR therapeutics Recent Development

Table 71. Intellia therapeutics, Inc. Company Details

Table 72. Intellia therapeutics, Inc. Business Overview

Table 73. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product

Table 74. Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026

Table 75. Intellia therapeutics, Inc. Recent Development

Table 76. Cellectis Company Details

Table 77. Cellectis Business Overview

Table 78. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product

Table 79. Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026

Table 80. Cellectis Recent Development

Table 81. Horizon Discovery Plc Company Details

Table 82. Horizon Discovery Plc Business Overview

Table 83. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product

Table 84. Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026

Table 85. Horizon Discovery Plc Recent Development

Table 86. Sigma Aldrich Company Details

Table 87. Sigma Aldrich Business Overview

Table 88. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product

Table 89. Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026

Table 90. Sigma Aldrich Recent Development

Table 91. Precision Biosciences Company Details

Table 92. Precision Biosciences Business Overview

Table 93. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product

Table 94. Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026

Table 95. Precision Biosciences Recent Development

Table 96. Genscript Company Details

Table 97. Genscript Business Overview

Table 98. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product

Table 99. Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026

Table 100. Genscript Recent Development

Table 101. Sangamo Biosciences Inc. Company Details

Table 102. Sangamo Biosciences Inc. Business Overview

Table 103. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product

Table 104. Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026

Table 105. Sangamo Biosciences Inc. Recent Development

Table 106. Lonza Group Limited Company Details

Table 107. Lonza Group Limited Business Overview

Table 108. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product

Table 109. Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026

Table 110. Lonza Group Limited Recent Development

Table 111. Integrated DNA Technologies Company Details

Table 112. Integrated DNA Technologies Business Overview

Table 113. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product

Table 114. Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026

Table 115. Integrated DNA Technologies Recent Development

Table 116. New England Biolabs Company Details

Table 117. New England Biolabs Business Overview

Table 118. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product

Table 119. New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026

Table 120. New England Biolabs Recent Development

Table 121. Origene Technologies Company Details

Table 122. Origene Technologies Business Overview

Table 123. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product

Table 124. Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026

Table 125. Origene Technologies Recent Development

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

Table 129. Authors List of This Report

List of Figures

Figure 1. CRISPR and CRISPR-Associated (Cas) Genes Picture

Figure 2. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type: 2025 vs 2032

Figure 4. Genome Editing Features

Figure 5. Genetic engineering Features

Figure 6. gRNA Database/Gene Librar Features

Figure 7. CRISPR Plasmid Features

Figure 8. Human Stem Cells Features

Figure 9. Genetically Modified Organisms/Crops Features

Figure 10. Cell Line Engineering Features

Figure 11. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (US$ Million), 2021–2032

Figure 12. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application: 2025 vs 2032

Figure 13. Biotechnology Companies Case Studies

Figure 14. Pharmaceutical Companies Case Studies

Figure 15. Academic Institutes Case Studies

Figure 16. Research and Development Institutes Case Studies

Figure 17. CRISPR and CRISPR-Associated (Cas) Genes Report Years Considered

Figure 18. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 19. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 20. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region: 2025 vs 2032

Figure 21. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Players in 2025

Figure 22. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 23. The Top 10 and 5 Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2025

Figure 24. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2021–2032)

Figure 26. United States CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Canada CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2021–2032)

Figure 30. Germany CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. France CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. U.K. CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Italy CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Russia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Ireland CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2021–2032)

Figure 38. China CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. South Korea CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. India CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Australia & New Zealand CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2021–2032)

Figure 46. Mexico CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Brazil CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2021–2032)

Figure 50. Israel CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Saudi Arabia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. UAE CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Thermo Fisher Scientific Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

Figure 54. Editas Medicine Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

Figure 55. Caribou Biosciences Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

Figure 56. CRISPR therapeutics Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

Figure 57. Intellia therapeutics, Inc. Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

Figure 58. Cellectis Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

Figure 59. Horizon Discovery Plc Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

Figure 60. Sigma Aldrich Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

Figure 61. Precision Biosciences Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

Figure 62. Genscript Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

Figure 63. Sangamo Biosciences Inc. Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

Figure 64. Lonza Group Limited Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

Figure 65. Integrated DNA Technologies Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

Figure 66. New England Biolabs Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

Figure 67. Origene Technologies Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global CRISPR Cas Genes Market Research Report 2024

Global CRISPR associated Nucleases Market Research Report 2024

Global CRISPER associated Nucleases Market Research Report 2024

CRISPR in Agriculture Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global CRISPR Kit Market Research Report 2024

Global CRISPR Gene Editing Market Research Report 2024

Global CRISPR Genome Editing Market Insights Forecast to 2030

Global Plant Breeding and CRISPR Plants Market Insights Forecast to 2030

Global CRISPR Gene Editing Tools Market Research Report 2024

Global CRISPR Based Therapeutics Market Research Report 2024

Prime Editing Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global CRISPR Knockout Cell Lines Market Research Report 2025

Global CRISPR Cell Line Development Market Research Report 2024

Global CRISPR Cas9 Gene Editing Service Market Research Report 2025

Global CRISPR Cas9 Nuclease Market Research Report 2024

Global CRISPR Gene Testing and Diagnostics Market Research Report 2024

Global Crispr Genomic Cure Market Research Report 2024

Global CRISPR Gene Detection and Diagnostic Market Research Report 2024

Global Gene Editing Tools Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions